Log In | Subscribe | Sitemap
HOME
Retail Updates
QASA Market Updates
  • Afghanistan is attempting to increase trading billateral and investment with Indonesia
  • UNCTAD: Dari Posisi 8, Indonesia Kini Posisi 4 Negara Tujuan Investasi
  • UNCTAD: From 8th Rank, Indonesia is at 4th position as an investment destination country
Categories
• Samples  • Agriculture  • Heavy Equipment  • Packaging  • Electronic  • Home Appliance  • Infrastructure  • Shariah Finance  • Banking  • Telecommunication  • Manufacture  • Mining  • Garment  • Retail  • Wholesale  • Construction  • Finance  • Investment  • poultry  • Automotive  • FMCG  • Information Technology  • Services  • Transportation  • Electric  • Pharmaceutical  • Advertising  • Regulation  • Commercial Economy  • Property  • Food & Beverage  • Chemical  • Economy 
  • 2017
  • 2015
  • 2014
  • 2012
  • 2011
  • 2010
  • QASA Market Updates • Updates • Pharmaceutical
     

    Nowaday, pharmaceutical import products still dominated in Indonesia market.


    As the largest public health product company in Southeast Asia, PT Kalbe Farma Tbk continues to innovate to improve products and services.


    Although the implementation of National Health Insurance (JKN) System has been effectived, pharmaceutical company sales growth in 2014 is still slowing compared to last year.


    Applicability of the National Social Security System (SJSN) in 2014 is expected to inflate demand for generic drugs


    Investment by foreign pharmaceutical producers are valued at U.S. $ 44 million


    Some drug manufacturers began to increase production capacity


    Time to time continue to show improvement


    PT Rohto Laboratories Indonesia and PT L'Oreal Indonesia, will build the plant this year


    Indonesia's pharmaceutical market is expected to grow in the fourth highest position in the Asia Pacific region


    National cosmetics sales in the first semester of 2012 is expected to grow 14.9 percent


    The potential for market growth in generic drugs and medical devices is estimated to reach Rp 9.2 billion


    The production cost of medicine year-to-date is relatively stable


    PT Kimia Farma Tbk plans to form a joint venture with Japanese companies led by Mitsui Corporation


    PT Indofarma Tbk plans to build two manufactories in the second semester of 2012


    The Minister of Health estimates the medical equipment market will grow 5% year-on-year to Rp 7 trillion this year


    PT Kimia Farma Tbk and PT Tigaka Distrindo Perkasa signed a joint venture agreement with Tianjin Pharmaceutical Group Co.,Ltd


    PT Bayer Indonesia is targeting sales in the next five years to reach  400 million Euro


    Local pharmaceutical companies control the prescription drugs market in Indonesia


    Sales of generic drugs is projected to triple in 2014


    Sales of prescription drugs in Indonesia in 2012 is projected at around Rp 28 trillion

    Page << 1 | 2 | 3 >>